URS
DNA icon

Utah Retirement Systems’s Ginkgo Bioworks DNA Stock Holding History

Utah Retirement Systems’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,140
Closed -$99.3K – 981
2024
Q1 		$99.3K Sell
2,140
-13
-0.6% -$673 ﹤0.01% 958
2023
Q4 		$146K Buy
2,153
+65
+3% +$3.98K ﹤0.01% 969
2023
Q3 		$151K Buy
2,088
+15
+0.7% +$1.2K ﹤0.01% 954
2023
Q2 		$154K Buy
2,073
+890
+75% +$52.7K ﹤0.01% 974
2023
Q1 		$62.9K Buy
1,183
+98
+9% +$6.21K ﹤0.01% 965
2022
Q4 		$73.3K Hold
1,085
– – ﹤0.01% 953
2022
Q3 		$135K Buy
1,085
+15
+1% +$1.79K ﹤0.01% 942
2022
Q2 		$102K Buy
+1,070
New +$131K ﹤0.01% 983

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Utah Retirement Systems's DNA Position: Q2 2024 in Review

Utah Retirement Systems sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 2,140 shares — an estimated $99.3K sold.

Utah Retirement Systems first reported a position in DNA in Q2 2022 and held it in 8 quarters. The position peaked at $154K in Q2 2023. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Utah Retirement Systems reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Utah Retirement Systems sold 2,140 Ginkgo Bioworks shares in Q2 2024, an estimated $99.3K.
  • Utah Retirement Systems first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 8 quarters.
  • Utah Retirement Systems's Ginkgo Bioworks position peaked at $154K in Q2 2023.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Utah Retirement Systems's 13F filing for Q2 2024, filed 14 Aug 2024.